Related Experiment Video
Updated: May 28, 2026

06:01
Clinicopathological Analysis of miRNA Expression in Breast Cancer Tissues by Using miRNA In Situ Hybridization
Published on: June 7, 2016
[MicroRNA expression pattern in intraductal papillary mucinous neoplasm]
Yun Gyoung Park1, Kwang Hyuck Lee, Jong Kyun Lee
1Department of Internal Medicine, Division of Gastroenterology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
The Korean Journal of Gastroenterology = Taehan Sohwagi Hakhoe Chi
|November 2, 2011
Summary
Intraductal papillary mucinous neoplasms (IPMN) are pancreatic cancer precursors. This study identified specific microRNAs (miRNAs) overexpressed in IPMN and pancreatic cancer, finding that inhibiting these miRNAs reduced cancer cell proliferation.
Area of Science:
- Molecular biology
- Oncology
- Genetics
Context:
- Intraductal papillary mucinous neoplasms (IPMN) are recognized precursor lesions for pancreatic cancer.
- Aberrant microRNA (miRNA) expression is a hallmark of various cancers, suggesting their role in tumorigenesis.
- Understanding miRNA dysregulation in IPMN is crucial for early detection and therapeutic strategies.
Purpose:
- To analyze the expression patterns of microRNAs in IPMN tissues.
- To identify specific miRNAs that are aberrantly expressed in IPMN and pancreatic cancer.
- To evaluate the functional role of overexpressed miRNAs in pancreatic cancer cell proliferation.
Summary:
- MicroRNA expression profiling revealed 122 aberrantly expressed miRNAs in IPMN.
- miR-196a and miR-183 were significantly overexpressed in IPMN and pancreatic cancer cell lines compared to normal pancreatic ductal cells.
- Inhibition of miR-196a and miR-183 using anti-miRNA inhibitors led to a significant decrease in pancreatic cancer cell survival and proliferation.
Impact:
- Identifies miR-196a and miR-183 as potential biomarkers for IPMN and pancreatic cancer.
- Suggests that targeting these specific miRNAs could be a novel therapeutic approach for pancreatic cancer.
- Provides insights into the molecular mechanisms underlying IPMN progression and pancreatic cancer development.
Related Concept Videos
MicroRNAs
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...

